MYP_116196
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
10 amino acids
C42H64N12O19
Standard
Sequence
SEHEGSGPEL
Physicochemical Analysis
1041.03 Da
4.24
-3.44
-3.71
-0.3444
-1.39
0.13
-0.08
38.10
39.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
497.47
-6.88
16.0
17.0
33.0
73.0
2.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0119136 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
pancreatic cancer; HLA-B*38:01
ELISPOT
RECORD: Rec_0128725 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
pancreatic cancer; HLA-B*38:01
Flow cytometry
RECORD: Rec_0260685 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
pancreatic cancer; HLA-B*38:01
4.5111 μM
Predicted HLA-I binding